What To Watch In Pay-For-Delay Trial Against Merck, Glenmark
Merck and generic-drug maker Glenmark are set to start a trial this week on claims that they gouged buyers of Merck's blockbuster cholesterol drug Zetia by forging a pay-for-delay deal....To view the full article, register now.
Already a subscriber? Click here to view full article